ARTL
Artelo Biosciences·NASDAQ
--
--(--)
--
--(--)
ARTL fundamentals
During Q4 2025, Artelo Biosciences (ARTL) reported revenue of --, a YoY change of 0.00%. Net income was -4.17M, a YoY change of -10.27%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Sep 1, 2015 | Sep 1, 2016 | Dec 1, 2016 | Mar 1, 2017 | Jun 1, 2017 | Sep 1, 2017 | Dec 1, 2017 | Mar 1, 2018 | Jun 1, 2018 | Sep 1, 2018 | Dec 1, 2018 | Mar 1, 2019 | Jun 1, 2019 | Sep 1, 2019 | Dec 1, 2019 | Mar 1, 2020 | Jun 1, 2020 | Sep 1, 2020 | Dec 1, 2020 | Mar 1, 2021 | Jun 1, 2021 | Sep 1, 2021 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Nov 30, 2015 | Nov 30, 2016 | Feb 28, 2017 | May 31, 2017 | Aug 31, 2017 | Nov 30, 2017 | Feb 28, 2018 | May 31, 2018 | Aug 31, 2018 | Nov 30, 2018 | Feb 28, 2019 | May 31, 2019 | Aug 31, 2019 | Nov 30, 2019 | Feb 29, 2020 | May 31, 2020 | Aug 31, 2020 | Nov 30, 2020 | Feb 28, 2021 | May 31, 2021 | Aug 31, 2021 | Nov 30, 2021 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Aug 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 15.22K -- | 9.52K -37.47% | 11.99K -- | 95.72K -- | 115.55K -- | 277.06K +2811.18% | 798.46K +6556.64% | 577.86K +503.66% | 690.11K +497.23% | 556.90K +101.01% | 424.79K -46.80% | 344.88K -40.32% | 1.88M +172.85% | 1.34M +139.98% | 1.37M +222.64% | 951.39K +175.86% | 1.03M -45.43% | 1.44M +7.45% | 1.87M +36.26% | 2.25M +136.64% | -- -- | 2.55M +77.72% | 2.47M +32.32% | 2.39M +6.33% | 3.48M -- | 2.29M -10.19% | 1.78M -27.80% | 2.61M +9.19% | 3.24M -6.79% | 2.59M +12.96% | 2.51M +40.81% | 1.20M -54.28% | 3.81M +17.65% | 2.38M -8.11% | 3.15M +25.40% | 3.09M +158.49% | 2.79M -26.92% | 11.40M -- |
Selling, General and Administrative Expenses | 609 -- | 313 -48.60% | 3.80K -- | 19.30K -- | 87.45K -- | 136.64K +43553.67% | 31.00K +715.09% | 104.64K +442.19% | 236.30K +170.21% | 205.57K +50.45% | 57.99K +87.08% | 403.05K +285.18% | 286.24K +21.13% | 403.28K +96.18% | 433.85K +648.11% | 389.19K -3.44% | 1.54M +438.26% | 841.00K +108.54% | 1.01M +132.01% | 1.07M +176.00% | -- -- | 1.28M +52.08% | 1.42M +40.58% | 1.32M +22.51% | 1.75M -- | 1.06M -17.36% | 1.03M -27.07% | 1.03M -21.81% | 1.12M -36.23% | 1.08M +2.37% | 827.00K -19.86% | 870.00K -15.45% | 1.34M +19.71% | 995.00K -8.04% | 1.28M +54.66% | 1.81M +108.51% | 1.89M +41.69% | 5.98M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 2.77M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 5.96M -- | -- -- | -- -- | 1.03M -- | 1.12M -81.28% | 1.08M -- | 827.00K -- | 870.00K -15.45% | 1.34M +19.71% | 995.00K -8.04% | 1.28M +54.66% | 1.81M +108.51% | 1.89M +41.69% | 5.98M -- |
Research and Development Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | 33.08K -- | 647.47K -- | 236.84K -- | 332.47K -- | 184.04K +456.41% | 489.98K -24.32% | 184.20K -22.23% | 233.77K -29.69% | 666.94K +262.39% | 721.31K +47.21% | 258.68K +40.43% | 272.08K +16.39% | 595.00K -10.79% | 663.36K -8.03% | 951.20K +267.72% | -- -- | 1.27M +113.95% | 1.06M +59.19% | 1.08M +13.33% | 1.73M -- | 1.24M -2.99% | 752.00K -28.79% | 1.58M +47.03% | 2.12M +23.06% | 1.51M +22.02% | 1.69M +124.07% | 325.00K -79.50% | 2.48M +16.57% | 1.38M -8.16% | 1.87M +11.04% | 1.27M +292.31% | 893.00K -63.93% | 5.42M -- |
Other Operating Expenses | 14.61K -- | 9.20K -37.00% | 8.19K -- | 76.43K -- | 28.10K -- | 107.34K +1066.29% | 120.00K +1364.83% | 236.38K +209.29% | 121.35K +331.82% | 167.29K +55.85% | -123.18K -202.65% | -242.37K -202.53% | 1.36M +1023.16% | 266.23K +59.14% | 215.38K +274.85% | 303.52K +225.23% | -785.13K -157.61% | -- -- | 197.60K -8.26% | 226.04K -25.53% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -15.22K -- | -9.52K +37.47% | -11.99K -- | -95.72K -- | -115.55K -- | -277.06K -2811.18% | -798.46K -6556.64% | -577.86K -503.66% | -690.11K -497.23% | -556.90K -101.01% | -424.79K +46.80% | -344.88K +40.32% | -1.88M -172.85% | -1.34M -139.98% | -1.37M -222.64% | -951.39K -175.86% | -1.03M +45.43% | -1.44M -7.45% | -1.87M -36.26% | -2.25M -136.64% | -- -- | -2.55M -77.72% | -2.47M -32.32% | -2.39M -6.33% | -3.48M -- | -2.29M +10.19% | -1.78M +27.80% | -2.61M -9.19% | -3.24M +6.79% | -2.59M -12.96% | -2.51M -40.81% | -1.20M +54.28% | -3.81M -17.65% | -2.38M +8.11% | -3.15M -25.40% | -3.09M -158.49% | -2.79M +26.92% | -11.40M -- |
Non-Operating Income (Loss) | -- -- | -- -- | -1.02K -- | -907 -- | -177 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.04M -- | 30.09K -- | 408 -- | 204 -- | 301 -99.97% | 1.00K -96.68% | 1.59K +289.22% | 1.62K +694.12% | -- -- | 4.00K +300.00% | 22.00K +1285.39% | 64.00K +3850.62% | 137.00K -- | 124.00K +3000.00% | 185.00K +740.91% | 165.00K +157.81% | 167.00K +21.90% | 106.00K -14.52% | 79.00K -57.30% | 63.00K -61.82% | 34.00K -79.64% | 7.00K -93.40% | -71.00K -189.87% | -31.00K -149.21% | -1.38M -4158.82% | -1.48M -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 22.00K -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 30.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 207.00K -- | -- -- | -- -- | 165.00K -- | 167.00K -19.32% | 106.00K -- | 79.00K -- | 63.00K -61.82% | 34.00K -79.64% | 0 -100.00% | 0 -100.00% | 75.00K +19.05% | -137.00K -502.94% | -62.00K -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.04M -- | 30.09K -- | -- -- | -- -- | -29.50K -102.84% | -- -- | 1.33K -- | 984 -- | -- -- | 3.00K -- | 21.00K +1473.03% | 69.00K +6912.20% | -70.00K -- | 124.00K +4033.33% | 185.00K +780.95% | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -1.16M -- | -- -- |
Net Interest Expense | -- -- | -- -- | 1.02K -- | 907 -- | 177 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -408 -- | -204 -- | 198 -- | -1.00K -- | -253 +37.99% | -636 -211.76% | -- -- | -1.00K -- | -1.00K -295.26% | 5.00K +886.16% | 0 -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | 0 -- | -7.00K -- | 71.00K -- | 106.00K -- | 107.00K -- | 277.00K -- |
Interest Expense | -- -- | -- -- | 1.02K -- | 907 -- | 177 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 5.00K -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 72.00K -- | 111.00K -- | 94.00K -- | -- -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 408 -- | 204 -- | -198 -- | 1.00K -- | 253 -37.99% | 636 +211.76% | -- -- | 1.00K -- | 1.00K +295.26% | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 7.00K -- | 1.00K -- | 5.00K -- | -13.00K -- | -- -- |
Pretax Income From Continuing Operations | -15.22K -- | -9.52K +37.47% | -13.01K -- | -96.63K -- | -115.73K -- | -277.06K -2811.18% | -798.46K -6036.84% | -577.86K -498.00% | -690.11K -496.32% | -556.90K -101.01% | -424.79K +46.80% | -344.88K +40.32% | -845.60K -22.53% | -1.31M -134.58% | -1.37M -222.54% | -951.19K -175.80% | -1.03M -21.49% | -1.44M -9.85% | -1.87M -36.19% | -2.25M -136.52% | -1.89M -83.65% | -2.55M -77.56% | -2.45M -31.25% | -2.33M -3.57% | -3.34M -76.98% | -2.17M +14.91% | -1.60M +34.71% | -2.45M -5.11% | -3.07M +7.97% | -2.48M -14.53% | -2.43M -52.16% | -1.13M +53.78% | -3.78M -22.94% | -2.37M +4.47% | -3.22M -32.39% | -3.12M -175.62% | -4.17M -10.27% | -12.88M -- |
Income Tax Expense | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Income Tax Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -15.22K -- | -9.52K +37.47% | -13.01K -- | -96.63K -- | -115.73K -- | -277.06K -2811.18% | -798.46K -6036.84% | -577.86K -498.00% | -690.11K -496.32% | -556.90K -101.01% | -424.79K +46.80% | -344.88K +40.32% | -845.60K -22.53% | -1.31M -134.58% | -1.37M -222.54% | -951.19K -175.80% | -1.03M -21.49% | -1.44M -9.85% | -1.87M -36.19% | -2.25M -136.52% | -1.89M -83.65% | -2.55M -77.56% | -2.45M -31.25% | -2.33M -3.57% | -3.34M -76.98% | -2.17M +14.91% | -1.60M +34.71% | -2.45M -5.11% | -3.07M +7.97% | -2.48M -14.53% | -2.43M -52.16% | -1.13M +53.78% | -3.78M -22.94% | -2.37M +4.47% | -3.22M -32.39% | -3.12M -175.62% | -4.17M -10.27% | -12.88M -- |
Net Income Attributable to Owners of the Company | -15.22K -- | -9.52K +37.47% | -13.01K -- | -96.63K -- | -115.73K -- | -277.06K -2811.18% | -798.46K -6036.84% | -577.86K -498.00% | -690.11K -496.32% | -556.90K -101.01% | -424.79K +46.80% | -344.88K +40.32% | -845.60K -22.53% | -1.31M -134.58% | -1.37M -222.54% | -951.19K -175.80% | -1.03M -21.49% | -1.44M -9.85% | -1.87M -36.19% | -2.25M -136.52% | -- -- | -2.55M -77.56% | -2.45M -31.25% | -2.33M -3.57% | -3.34M -- | -2.17M +14.91% | -1.60M +34.71% | -2.45M -5.11% | -3.07M +7.97% | -2.48M -14.53% | -2.43M -52.16% | -1.13M +53.78% | -3.78M -22.94% | -2.37M +4.47% | -3.22M -32.39% | -3.12M -175.62% | -4.17M -10.27% | -12.88M -- |
Net Income Attributable to Common Stockholders | -15.22K -- | -9.52K +37.47% | -13.01K -- | -96.63K -- | -115.73K -- | -277.06K -2811.18% | -798.46K -6036.84% | -577.86K -498.00% | -690.11K -496.32% | -556.90K -101.01% | -424.79K +46.80% | -344.88K +40.32% | -845.60K -22.53% | -1.31M -134.58% | -1.37M -222.54% | -951.19K -175.80% | -1.03M -21.49% | -1.44M -9.85% | -1.87M -36.19% | -2.25M -136.52% | -- -- | -2.55M -77.56% | -2.45M -31.25% | -2.33M -3.57% | -3.34M -- | -2.17M +14.91% | -1.60M +34.71% | -2.45M -5.11% | -3.07M +7.97% | -2.48M -14.53% | -2.43M -52.16% | -1.13M +53.78% | -3.78M -22.94% | -2.37M +4.47% | -3.22M -32.39% | -3.12M -175.62% | -4.17M -10.27% | -12.88M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | -- -- | 657 -- | -1.02K -- | -1.25K -- | -10.06K -- | -596 -190.72% | 4.89K +576.88% | -3.61K -187.56% | 771 +107.66% | 421 +170.64% | 16.34K +234.37% | 9.42K +361.20% | 34.55K +4380.80% | 13.69K +3151.78% | -16.00K -197.90% | 373 -96.04% | 1.48K -95.71% | -31.62K -330.98% | -41.00K -156.25% | -112.00K -30126.81% | -212.00K -14395.35% | 134.00K +523.77% | 49.00K +219.51% | 4.00K +103.57% | 2.00K +100.94% | -4.00K -102.99% | -- -- | -- -- | -15.00K -850.00% | 16.00K +500.00% | -25.00K -- | -68.00K -- | 18.00K +220.00% | 5.00K -68.75% | -70.00K -- |
Total Comprehensive Income | -15.22K -- | -9.52K +37.47% | -13.01K -- | -96.63K -- | -115.07K -- | -278.08K -2821.95% | -799.72K -6046.48% | -587.92K -508.41% | -690.71K -500.24% | -552.01K -98.51% | -428.39K +46.43% | -344.11K +41.47% | -845.18K -22.36% | -1.29M -133.69% | -1.36M -217.63% | -916.64K -166.38% | -1.01M -19.93% | -1.45M -12.48% | -1.87M -37.10% | -2.25M -145.28% | -1.92M -89.25% | -2.59M -78.43% | -2.56M -37.28% | -2.54M -13.06% | -3.21M -67.08% | -2.12M +18.15% | -1.59M +37.72% | -2.45M +3.74% | -3.08M +3.99% | -2.48M -17.18% | -2.43M -52.54% | -1.15M +53.13% | -3.76M -22.26% | -2.40M +3.46% | -3.29M -35.18% | -3.10M -170.44% | -4.16M -10.61% | -12.95M -- |
Total Comprehensive Income Attributable to Owners of the Company | -15.22K -- | -9.52K +37.47% | -13.01K -- | -96.63K -- | -115.07K -- | -278.08K -2821.95% | -799.72K -6046.48% | -587.92K -508.41% | -690.71K -500.24% | -552.01K -98.51% | -428.39K +46.43% | -344.11K +41.47% | -845.18K -22.36% | -1.29M -133.69% | -1.36M -217.63% | -916.64K -166.38% | -1.01M -19.93% | -1.45M -12.48% | -1.87M -37.10% | -2.25M -145.28% | -- -- | -2.59M -78.43% | -2.56M -37.28% | -2.54M -13.06% | -3.21M -- | -2.12M +18.15% | -1.59M +37.72% | -2.45M +3.74% | -3.08M +3.99% | -2.48M -17.18% | -2.43M -52.54% | -1.15M +53.13% | -3.76M -22.26% | -2.40M +3.46% | -3.29M -35.18% | -3.10M -170.44% | -4.16M -10.61% | -12.95M -- |
Basic EPS | 0 -- | 0 -- | 0 -- | -0.01 -- | -- -- | -0.02 -- | -0.07 -- | -0.36 -3500.00% | -- -- | -0.32 -1500.00% | -0.22 -214.29% | -0.17 +52.78% | -0.25 -- | -0.39 -21.88% | -0.4 -81.82% | -0.27 -58.82% | -0.21 +16.00% | -0.14 +64.10% | -0.11 +72.50% | -0.1 +62.96% | -0.08 +61.90% | -0.08 +42.86% | -0.87 -690.91% | -0.82 -720.00% | -1.17 -1362.50% | -0.76 -850.00% | -0.56 +35.63% | -0.83 -1.22% | -0.96 +17.95% | -0.78 -2.63% | -4.52 -707.14% | -2.1 -153.01% | -1.15 -19.79% | -0.72 +7.69% | -5.61 -24.12% | -3.97 -89.05% | -2.06 -79.13% | -12.36 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.83 -- | -- -- | -0.78 -- | -4.52 -- | -2.1 -153.01% | -- -- | -0.72 +7.69% | -5.61 -24.12% | -3.97 -89.05% | -- -- | -- -- |
Diluted EPS | 0 -- | 0 -- | 0 -- | -0.01 -- | -- -- | -0.02 -- | -0.07 -- | -0.36 -3500.00% | -- -- | -0.32 -1500.00% | -0.4 -471.43% | -0.17 +52.78% | -- -- | -0.39 -21.88% | -0.4 -- | -0.27 -58.82% | -- -- | -0.14 +64.10% | -0.11 +72.50% | -0.1 +62.96% | -- -- | -0.08 +42.86% | -0.87 -690.91% | -0.82 -720.00% | -- -- | -0.76 -850.00% | -0.56 +35.63% | -0.83 -1.22% | -- -- | -0.78 -2.63% | -4.52 -707.14% | -2.1 -153.01% | -- -- | -0.72 +7.69% | -5.61 -24.12% | -3.97 -89.05% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.83 -- | -- -- | -0.78 -- | -4.52 -- | -2.1 -153.01% | -- -- | -0.72 +7.69% | -5.61 -24.12% | -3.97 -89.05% | -- -- | -- -- |
You can ask Aime
What is the revenue and EPS growth rate for Artelo Biosciences year over year?What does Artelo Biosciences do and what are its main business segments?What is Artelo Biosciences's latest dividend and current dividend yield?What were the key takeaways from Artelo Biosciences's earnings call?What were the key takeaways from Artelo Biosciences’s earnings call?What guidance did Artelo Biosciences's management provide for the next earnings period?What factors drove the changes in Artelo Biosciences's revenue and profit?What is Artelo Biosciences's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
